Gilead Sciences Inc. Equity-NMS: GILD

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$112.39
Open :$110.51
Today's high :$112.38
Today's low :$110.28
52W low :$59.8241
52W high :$119.1239
EPS(TTM): :0.38
Shares O/S :1.25 B
Market cap :139.61 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Gilead Sciences Inc. $- +0.54% 295.76 139.61B

Frequently Asked Questions

What is the share price of Gilead Sciences Inc. today?

Gilead Sciences Inc. (GILD) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Gilead Sciences Inc.

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Anitocabtagene autoleucel, Sacituzumab govitecan-hziy, and Domvanalimab and zimberelimab. Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. It operates in more than 35 countries worldwide.